NCT03111173 Can Conventional ECG Technology Capture Fetal Cardiac Activity?
| NCT ID | NCT03111173 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Fetal Monitoring |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2017-06-02 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2017-06-02 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a feasibility study for a new application for capturing fetal cardiac activity. The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device.
Eligibility Criteria
Inclusion Criteria: * Singleton or twin pregnant women at 32 weeks gestation to full term after routine antepartum testing. Exclusion Criteria: * None.
Contact & Investigator
Martin G Frasch, MD, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT03111173 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Fetal Monitoring. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03111173 currently recruiting?
Yes, NCT03111173 is actively recruiting participants. Contact the research team at mfrasch@uw.edu for enrollment information.
Where is the NCT03111173 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT03111173 clinical trial?
NCT03111173 is sponsored by University of Washington. The principal investigator is Martin G Frasch, MD, PhD at University of Washington. The trial plans to enroll 50 participants.